Cargando…
Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran
BACKGROUND: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a serious and well-known complication of systemic lupus erythematosus (SLE). There is limited evidence about the prevalence of NPSLE and its manifestations in Iran. The aim of this study was to study clinical and demographic charac...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815521/ https://www.ncbi.nlm.nih.gov/pubmed/27099856 http://dx.doi.org/10.4103/2277-9175.178795 |
_version_ | 1782424604263841792 |
---|---|
author | Hajighaemi, Fatemeh Etemadifar, Masoud Bonakdar, Zahra Sayed |
author_facet | Hajighaemi, Fatemeh Etemadifar, Masoud Bonakdar, Zahra Sayed |
author_sort | Hajighaemi, Fatemeh |
collection | PubMed |
description | BACKGROUND: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a serious and well-known complication of systemic lupus erythematosus (SLE). There is limited evidence about the prevalence of NPSLE and its manifestations in Iran. The aim of this study was to study clinical and demographic characteristics of patients with NPSLE in an Iranian population. MATERIALS AND METHODS: This was a cross-sectional study that was undertaken in two referral Clinics of Neurological and Rheumatological Disorders in Alzahra Hospital, Isfahan, Iran. Between March 2004 and June 2010, medical records of registered patients with SLE were examined. NPSLE was characterized using the American College of Rheumatology case definitions. Descriptive statistics and logistic regression were performed for statistical assessment. RESULTS: Among 556 patients with SLE, 121 (21.7%) patients were diagnosed as NPSLE and enrolled in the study. Of whom, 94 patients were female (77.7%) and 27 patients were male (22.3%) with a female to male ratio of 3.48:1. The most common NPSLE manifestations were headache (38.8%), cerebrovascular disease (CVD) (38.8%) and seizure (26.4%). Thirty-nine patients have psychiatric disorders. Among them, 32 patients (26.4%) have periods of psychosis and mood disorder was found in 6 patients (5%). CONCLUSIONS: We identified NPSLE manifestations in 21.7% of patients; headache and CVD were the most frequent neurological manifestations. Continued studies into the pathogenesis of neurological involvement in patients with SLE are warranted. |
format | Online Article Text |
id | pubmed-4815521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-48155212016-04-20 Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran Hajighaemi, Fatemeh Etemadifar, Masoud Bonakdar, Zahra Sayed Adv Biomed Res Original Article BACKGROUND: Neuropsychiatric systemic lupus erythematosus (NPSLE) is a serious and well-known complication of systemic lupus erythematosus (SLE). There is limited evidence about the prevalence of NPSLE and its manifestations in Iran. The aim of this study was to study clinical and demographic characteristics of patients with NPSLE in an Iranian population. MATERIALS AND METHODS: This was a cross-sectional study that was undertaken in two referral Clinics of Neurological and Rheumatological Disorders in Alzahra Hospital, Isfahan, Iran. Between March 2004 and June 2010, medical records of registered patients with SLE were examined. NPSLE was characterized using the American College of Rheumatology case definitions. Descriptive statistics and logistic regression were performed for statistical assessment. RESULTS: Among 556 patients with SLE, 121 (21.7%) patients were diagnosed as NPSLE and enrolled in the study. Of whom, 94 patients were female (77.7%) and 27 patients were male (22.3%) with a female to male ratio of 3.48:1. The most common NPSLE manifestations were headache (38.8%), cerebrovascular disease (CVD) (38.8%) and seizure (26.4%). Thirty-nine patients have psychiatric disorders. Among them, 32 patients (26.4%) have periods of psychosis and mood disorder was found in 6 patients (5%). CONCLUSIONS: We identified NPSLE manifestations in 21.7% of patients; headache and CVD were the most frequent neurological manifestations. Continued studies into the pathogenesis of neurological involvement in patients with SLE are warranted. Medknow Publications & Media Pvt Ltd 2016-03-16 /pmc/articles/PMC4815521/ /pubmed/27099856 http://dx.doi.org/10.4103/2277-9175.178795 Text en Copyright: © 2016 Advanced Biomedical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Hajighaemi, Fatemeh Etemadifar, Masoud Bonakdar, Zahra Sayed Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran |
title | Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran |
title_full | Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran |
title_fullStr | Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran |
title_full_unstemmed | Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran |
title_short | Neuropsychiatric manifestations in patients with systemic lupus erythematosus: A study from Iran |
title_sort | neuropsychiatric manifestations in patients with systemic lupus erythematosus: a study from iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815521/ https://www.ncbi.nlm.nih.gov/pubmed/27099856 http://dx.doi.org/10.4103/2277-9175.178795 |
work_keys_str_mv | AT hajighaemifatemeh neuropsychiatricmanifestationsinpatientswithsystemiclupuserythematosusastudyfromiran AT etemadifarmasoud neuropsychiatricmanifestationsinpatientswithsystemiclupuserythematosusastudyfromiran AT bonakdarzahrasayed neuropsychiatricmanifestationsinpatientswithsystemiclupuserythematosusastudyfromiran |